Company Filing History:
Years Active: 2022-2025
Title: Guy Poland - Innovator in Teverelix-TFA Compositions
Introduction
Guy Poland is a notable inventor based in Bristol, GB. He has made significant contributions to the field of pharmaceutical compositions, particularly focusing on teverelix-TFA compositions. With a total of 5 patents to his name, Poland has demonstrated a commitment to innovation and excellence in his work.
Latest Patents
Poland's latest patents include a reconstitutable teverelix-TFA composition. This invention relates to a composition that maintains a predefined molar ratio of teverelix to trifluoroacetate, which is below the molar ratio required for microcrystal formation. The composition remains stable during storage at temperatures around 2-8° C. Upon reconstitution, a fixed amount of trifluoroacetate can be added, achieving an exact and desired molar ratio to obtain a fluid, milky microcrystalline aqueous teverelix-TFA suspension. Another significant patent is the teverelix-TFA composition, which has a molar ratio of teverelix to trifluoroacetate of at least 1:2.2. This specific molar ratio prevents undesirable gel formation and provides a homogeneous suspension, resulting in a unique bioavailability of teverelix.
Career Highlights
Guy Poland is currently associated with Antev Limited, where he continues to develop innovative solutions in the pharmaceutical industry. His work has been instrumental in advancing the understanding and application of teverelix-TFA compositions.
Collaborations
Poland collaborates with talented individuals such as Francois Boutignon and Finn Larsen, contributing to a dynamic and innovative work environment.
Conclusion
Guy Poland's contributions to the field of pharmaceutical compositions, particularly through his patents on teverelix-TFA, highlight his role as a significant innovator. His work continues to impact the industry positively, showcasing the importance of innovation in developing effective pharmaceutical solutions.